Kajian klinikal Diabetes di Colorado
16 kajian untuk Diabetes sedang mencari peserta di lokasi di Colorado.
Bandar di Colorado
Teks kajian rasmi (Bahasa Inggeris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Western Nephrology, Arvada
- Kidney Associates of Colorado, P.C., Denver
- Colorado Kidney Care, Denver
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Barbara Davis Center for Childhood Diabetes, Aurora
Mengambil pesertaFasa 1/2
Umur 12 hingga 35 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06783309SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
- University of Colorado, Aurora
Mengambil pesertaFasa awal 1
Umur 14 hingga 24 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07409714INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Barbara Davis Center for Diabetes Young Adult Clinic, Aurora
Mengambil pesertaFasa 2
Umur 6 hingga 17 · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT07224321Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
- Children's Hospital Colorado - Center for Cancer and Blood Disorders (CCBD) - Anschutz Medical Campus Location, Aurora
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Jun 2026 · NCT05650229Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
- University of Colorado Anschutz Medical Campus, Aurora
Mengambil peserta
Umur 18 hingga 89 · Semua jantina · Dikemas kini 11 Jun 2026 · NCT07011147GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- Children's Hospital of Colorado, Aurora
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT04731272Pancreas Ultrasound Imaging in type1 Diabetes
- University of Colorado Anschutz, Barbara Davis Center, Aurora
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 6 Mei 2026 · NCT05482321Supporting VETerans With Kidney Disease Through Food As Medicine
- Rocky Mountain Regional VA Medical Center, Aurora
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mei 2026 · NCT07194733Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Mengambil peserta
Umur 40 hingga 89 · Semua jantina · Dikemas kini 13 Apr 2026 · NCT03995238Project Dulce for Arab Americans With Type 2 Diabetes
- Metro Caring, Denver
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT05580536Colorado Community Engagement Alliance
- University of Colorado - Anschutz Medical Campus, Aurora
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 90 · Semua jantina · Dikemas kini 27 Feb 2026 · NCT07440316Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
- University of Colorado Denver, Aurora
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 10 Feb 2026 · NCT06837181North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
- Children's Hospital of Colorado, Aurora
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Semua umur · Semua jantina · Dikemas kini 4 Feb 2026 · NCT01694940Rare and Atypical Diabetes Network
- University of Colorado- Denver, Aurora
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 14 Ogo 2025 · NCT05544266Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
- University of Colorado Anschutz Medical Campus, Aurora
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Mei 2025 · NCT06140537Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.